文献速递胸部介入技术与安全CT

非诊断性肺活检后放射科医师预测恶性风险的价值

Nondiagnostic Lung Biopsies: Radiologist Performance in Prediction of Malignancy.
PubMed 文献 · Acad Radiol · 2026-08-26

本研究回顾性纳入2020—2022年142例CT引导或锥形束CT引导肺活检后结果为非诊断性的病例,其中25.4%最终证实为恶性。由2名胸部放射科医师和2名高年资住院医师结合临床、影像及病理资料进行5级评分,评估预测恶性可能性。结果显示胸部放射科医师以≥4分为阈值时敏感度为91.7%,特异度分别为94.3%和89.6%,观察者间一致性良好。

要点

  • 非诊断性肺活检中约四分之一最终为恶性,不能轻易视为良性。
  • 活检见不典型细胞、正常肺组织或坏死时恶性率较高,需提高警惕。
  • 胸部放射科医师综合临床、影像与病理信息可较准确预测恶性风险。

核心结论

  • 胸部放射科医师整合临床、影像及组织病理信息后,能准确预测非诊断性肺活检病灶的恶性可能性。
  • 采用5级评分中≥4分为阈值时,两名胸部放射科医师敏感度均为91.7%,特异度分别为94.3%和89.6%。
  • 评分为「明确良性」时预测恶性概率低于1%,评分为「明确恶性」时预测恶性概率超过95%。

研究设计与样本

  • 回顾性研究,纳入2020—2022年间CT引导经胸穿刺或锥形束CT引导支气管镜肺活检结果为非诊断性的全部患者。
  • 共纳入142例非诊断性活检,来自131例患者,平均年龄66±14.8岁。
  • 最终诊断通过重复活检、手术切除或随访影像确定良性或恶性。
  • 由2名胸部放射科医师和2名高年资住院医师在复习临床病史、影像检查及组织病理资料后独立进行5级评分。
  • 诊断效能采用敏感度、特异度和曲线下面积评估,观察者间一致性采用二次加权Cohen κ检验。

关键影像表现/征象

  • 活检表现为不典型细胞的病灶恶性率最高,为16/18。
  • 活检见正常肺组织的病灶恶性率为11/20。
  • 活检见坏死的病灶恶性率为3/6。
  • 机化性肺炎相关病灶恶性率为6.7%。

诊断标准与关键数值

  • 以评分≥4为阈值时,两名胸部放射科医师敏感度均为91.7%(95%CI 77.5-98.2%)。
  • 以评分≥4为阈值时,两名胸部放射科医师特异度分别为94.3%(95%CI 88.1-97.9%)和89.6%(95%CI 82.2-94.7%)。
  • 两名胸部放射科医师AUC差异无统计学意义(p=0.32)。
  • 两名胸部放射科医师观察者间一致性极佳,κ=0.82。
  • 逻辑回归显示评分为「明确良性」时预测恶性概率低于1%,评分为「明确恶性」时预测恶性概率超过95%。

临床应用与阅片要点

  • 对非诊断性肺活检病例,应结合活检病理提示的不典型细胞、正常肺组织或坏死等线索调整恶性风险判断。
  • 采用5级评分中≥4分作为建议进一步处理或考虑恶性的参考阈值,具有较高敏感度和特异度。
  • 胸部放射科医师在报告或会诊中可通过综合临床、影像与病理信息给出恶性概率分级。

局限性

  • 研究为回顾性设计,存在选择偏倚可能。
  • 最终诊断依赖重复活检、手术切除或随访影像,部分病例随访时间可能不足。
  • 来自单中心经验,样本量142例,结论外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

RATIONALE AND OBJECTIVES: To determine outcomes of nondiagnostic lung biopsies and assess thoracic radiologist performance for predicting the likelihood of malignancy.

MATERIALS AND METHODS: We retrospectively identified all patients who underwent computed tomography (CT)-guided transthoracic or cone-beam CT-guided bronchoscopic lung biopsy between 2020 and 2022 with nondiagnostic results. The final diagnostic outcome (benign vs malignant) was determined through repeat biopsy, surgical excision, or follow-up imaging. Two thoracic radiologists and two senior residents independently assigned a 5-point score after reviewing relevant clinical history, imaging studies, and histopathological data. Diagnostic performance was assessed using sensitivity, specificity, and area under the curve (AUC). Interobserver agreement was measured with the quadratic-weighted Cohen's κ test. Logistic regression was used to model predicted malignancy probability across the 5-point scale.

RESULTS: We included 142 nondiagnostic biopsies in 131 patients (mean age, 66 ± 14.8 years); 36 lesions (25.4%) were malignant. Malignancy rates were highest among lesions with atypical cells (16/18), normal lung tissue (11/20), and necrosis (3/6). Organizing pneumonia was associated with malignancy in 6.7% of cases. Using a score threshold ≥4, both thoracic radiologists achieved an identical sensitivity of 91.7% (95% confidence interval 77.5-98.2%), and specificities of 94.3% (88.1-97.9%) and 89.6% (82.2-94.7%) with no significant difference in AUC (p = 0.32). Interobserver agreement between the two thoracic radiologists was excellent (κ = 0.82). Logistic regression demonstrated <1% predicted malignancy at score 1 ("definitely benign") and >95% malignancy at score 5 ("definitely malignant").

CONCLUSION: Thoracic radiologists accurately predicted malignancy likelihood after nondiagnostic lung biopsy by integrating clinical, imaging, and histopathologic data.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Altmayer, Guo, Lin, et al. Nondiagnostic Lung Biopsies: Radiologist Performance in Prediction of Malignancy. Acad Radiol. 2026. PMID: 42648924. doi:10.1016/j.acra.2026.07.078

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。